title: [Clinical study of male urethritis in Oogaki Municipal Hospital].
abstract: We studied 181 patients diagnosed with male urethritis at Oogaki Municipal Hospital from April 2002 to March 2004. Twenty-two out of 92 patients diagnosed with gonococcal urethritis (GU) and 52 out of 89 patients diagnosed with non-gonococcal urethritis (NGU) were positive for Chlamidia trichomatis by polymerase chain reaction (PCR). Most patients of male urethritis were in their twenties. Of GU patients, 39 (67%) were infected from commercial sex workers (CSWs). Of NGU patients, 12 (30%) were infected from CSWs, 24 (40%) from girl friends and 4 (10%) from their Twenty-eight (48%) out of GU patients were infected through oral sex. spouse. Eighty-three GU patients were treated with SPCM (2 g, one shot). Fifty-five patients could be evaluated for the efficacy of treatment. Elimination rate of Neisseria gonorrhoeae was 100% and 14 out of 18 patients with persisting urethritis had C. trichomatis. Eighty-two NGU patients were treated with minocycline, tosufloxacin, levofloxacin, gatiflixacin or clarithromycine. Sixty-six patients could be evaluated for the efficacy of treatment. Forty-one patients were diagnosed with non-gonococcal chlamydial urethritis (NGCU) and 25 patients were diagnosed with non-gonococcal, non-chlamydial urethritis (NGNCU). The clinical curative rate of NGCU and NGNCU was 93% (38/41) and 80% (20/25), respectively.
authors.affiliation: The Department of Urology, Oogaki Municipal Hospital.
authors.forename: Hisao
authors.initials: H
authors.lastname: Komeda
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Fujimoto
authors.forename: Masahiro
authors.initials: M
authors.lastname: Uno
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Takada
authors.forename: Yoshiteru
authors.initials: Y
authors.lastname: Yamada
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy / Q000453:epidemiology; D024841:Fluoroquinolones / Q000627:therapeutic use; D006069:Gonorrhea / Q000188:drug therapy / Q000453:epidemiology; D006773:Hospitals, Municipal; D006801:Humans; D007564:Japan / Q000453:epidemiology; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000627:therapeutic use; D009287:Naphthyridines / Q000627:therapeutic use; D015242:Ofloxacin / Q000627:therapeutic use; D012747:Sexual Partners; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy* / Q000453:epidemiology*; D000198:Spectinomycin / Q000627:therapeutic use*; D014526:Urethritis / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D064704:Levofloxacin; D000198:Spectinomycin; D015242:Ofloxacin; D008911:Minocycline; C055185:tosufloxacin